NFKB1 and lung carcinoma: In both colorectal and lung carcinoma, NF-κB plays a key role in pathological angiogenesis, and strategies to inhibit NF-κB are effective in decreasing tumors (Debusk et al., 2008; Sakamoto et al., 2009; Panahi et al., 2016).